Which Patients with Upper Tract Urothelial Carcinoma Can be Safely Treated with Flexible Ureteroscopy with Holmium:YAG Laser Photoablation? Long-Term Results from a High Volume Institution

被引:66
作者
Villa, Luca [1 ,3 ]
Haddad, Mattieu [1 ]
Capitanio, Umberto [3 ]
Somani, Bhaskar K. [1 ,5 ]
Cloutier, Jonathan [1 ]
Doizi, Steeve [1 ]
Salonia, Andrea [4 ]
Briganti, Alberto [4 ]
Montorsi, Francesco [4 ]
Traxer, Olivier [2 ]
机构
[1] Pierre & Marie Curie Univ, Tenon Hosp, Dept Urol, 4 Rue Chine, F-75970 Paris 20, France
[2] Grp Rech Clin Lithiase 20, Paris, France
[3] Osped San Raffaele, Div Expt Oncol, Unit Urol, Urol Res Inst,Ist Ricovero & Cura Carattere Sci, Milan, Italy
[4] Univ Vita Salute San Raffaele, Milan, Italy
[5] Univ Hosp Southampton Natl Hlth Serv Trust, Dept Urol, Southampton, Hants, England
关键词
urinary tract; urothelium; carcinoma; laser therapy; ureteroscopy; UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; RADICAL NEPHROURETERECTOMY; CONSERVATIVE MANAGEMENT; ENDOSCOPIC MANAGEMENT; DIGITAL URETEROSCOPY; OUTCOMES; BIOPSY; GUIDELINES; EXPERIENCE;
D O I
10.1016/j.juro.2017.07.088
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We tested the effects of tumor size, distribution and grade on progression-free survival in patients with upper tract urothelial carcinoma treated with flexible ureteroscopy with Ho:YAG laser photoablation. Materials and Methods: Included in analysis were data on 92 consecutive patients with upper tract urothelial carcinoma treated with Ho:YAG laser photoablation from 2003 to 2015 at a single tertiary care referral center. Stringent followup was offered according to EAU (European Association of Urology) guidelines. Progression during followup was defined by tumor upgrading, distant metastases and/or a relapsing tumor that could not be completely removed with a conservative approach. Kaplan-Meier curves were used to assess the rate of disease progression according to tumor size (1 or less cm vs greater than 1 cm), tumor distribution (unifocal vs multifocal) and tumor grade (low vs high). Cox regression analysis was done to test the impact of clinical and pathological characteristics on the rate of progression-free survival. Results: At a median followup of 52 months (IQR 27.8-76.4) the progression-free survival rate was 68% vs 72% in patients with a tumor size of 1 or less vs greater than 1 cm (p=0.9), 72% vs 69% in patients with unifocal vs multifocal lesions (p=0.6) and 75% vs 52% in patients with a low vs a high grade tumor (p=0.03). On multivariable Cox regression analysis tumor grade at first treatment was the only independent predictor of disease progression (HR 5.16, 95% CI 1.19-22.26, p=0.03). Conclusions: High tumor grade independently decreased progression-free survival in patients with upper tract urothelial carcinoma treated with Ho:YAG laser photoablation. Tumor size greater than 1 cm and multifocality did not increase the risk of disease progression in patients treated conservatively with Ho:YAG laser photoablation.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 28 条
  • [1] Digital ureteroscopy: The next step
    Andonian, Sero
    Okeke, Zeph
    Smith, Arthur D.
    [J]. JOURNAL OF ENDOUROLOGY, 2008, 22 (04) : 603 - 605
  • [2] Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes
    Audenet, Francois
    Traxer, Olivier
    Bensalah, Karim
    Roupret, Morgan
    [J]. WORLD JOURNAL OF UROLOGY, 2013, 31 (01) : 45 - 52
  • [3] Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract
    Audenet, Francois
    Traxer, Olivier
    Yates, David R.
    Cussenot, Olivier
    Roupret, Morgan
    [J]. BJU INTERNATIONAL, 2012, 109 (04) : 608 - 613
  • [4] Preoperative Hydronephrosis, Ureteroscopic Biopsy Grade and Urinary Cytology Can Improve Prediction of Advanced Upper Tract Urothelial Carcinoma
    Brien, James C.
    Shariat, Shahrokh F.
    Herman, Michael P.
    Ng, Casey K.
    Scherr, Douglas S.
    Scoll, Benjamin
    Uzzo, Robert G.
    Wille, Mark
    Eggener, Scott E.
    Terrell, John D.
    Lucas, Steven M.
    Lotan, Yair
    Boorjian, Stephen A.
    Raman, Jay D.
    [J]. JOURNAL OF UROLOGY, 2010, 184 (01) : 69 - 73
  • [5] The Impact of Tumor Multifocality on Outcomes in Patients Treated With Radical Nephroureterectomy
    Chromecki, Thomas F.
    Cha, Eugene K.
    Fajkovic, Harun
    Margulis, Vitaly
    Novara, Giacomo
    Scherr, Douglas S.
    Lotan, Yair
    Raman, Jay D.
    Kassouf, Wassim
    Bensalah, Karim
    Weizer, Alon
    Kikuchi, Eiji
    Roscigno, Marco
    Remzi, Mesut
    Matsumoto, Kazumasa
    Walton, Thomas J.
    Pycha, Armin
    Ficarra, Vincenzo
    Karakiewicz, Pierre I.
    Zigeuner, Richard
    Pummer, Karl
    Shariat, Shahrokh F.
    [J]. EUROPEAN UROLOGY, 2012, 61 (02) : 245 - 253
  • [6] High-Grade Ureteroscopic Biopsy Is Associated with Advanced Pathology of Upper-Tract Urothelial Carcinoma Tumors at Definitive Surgical Resection
    Clements, Thomas
    Messer, Jamie C.
    Terrell, John D.
    Herman, Michael P.
    Ng, Casey K.
    Scherr, Douglas S.
    Scoll, Benjamin
    Boorjian, Stephen A.
    Uzzo, Robert G.
    Wille, Mark
    Eggener, Scott E.
    Lucas, Steven M.
    Lotan, Yair
    Shariat, Shahrokh F.
    Raman, Jay D.
    [J]. JOURNAL OF ENDOUROLOGY, 2012, 26 (04) : 398 - 402
  • [7] Conservative Management of Upper Tract Urothelial Carcinoma in France: A 2004-2011 National Practice Report
    Colin, Pierre
    Roupret, Morgan
    Ghoneim, Tarek P.
    Traxer, Olivier
    Zerbib, Marc
    Xylinas, Evanguelos
    [J]. EUROPEAN UROLOGY, 2013, 63 (02) : 405 - 406
  • [8] Endoscopic Versus Laparoscopic Management of Noninvasive Upper Tract Urothelial Carcinoma: 20-Year Single Center Experience
    Cutress, Mark L.
    Stewart, Grant D.
    Tudor, Edward C. G.
    Egong, Eric A.
    Wells-Cole, Simon
    Phipps, Simon
    Thomas, Ben G.
    Riddick, Antony C. P.
    McNeill, S. Alan
    Tolley, David A.
    [J]. JOURNAL OF UROLOGY, 2013, 189 (06) : 2054 - 2060
  • [9] Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience
    Cutress, Mark L.
    Stewart, Grant D.
    Wells-Cole, Simon
    Phipps, Simon
    Thomas, Ben G.
    Tolley, David A.
    [J]. BJU INTERNATIONAL, 2012, 110 (11) : 1608 - 1617
  • [10] Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients
    Grasso, Michael
    Fishman, Andrew I.
    Cohen, Jacob
    Alexander, Bobby
    [J]. BJU INTERNATIONAL, 2012, 110 (11) : 1618 - 1626